ArticlePloS one2019

The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis.

Federico Prefumo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.